GHRP-2 is pralmorelin, a six-residue synthetic secretagogue containing D-amino acids and 2-naphthylalanine. Free-base identity, acetate form and peptide-equivalent content must be reported separately.
Evidence at a glance
- PubChem lists H-D-Ala-D-2Nal-Ala-Trp-D-Phe-Lys-NH2, formula C45H55N9O6 and molecular weight 818.0 g/mol.
- The shorthand sequence AXAWFK cannot by itself encode the two D residues or the nonstandard 2Nal residue.
- Area-percent purity does not establish acetate, water or absolute peptide content.
Identity record
A mass match alone cannot prove residue order or stereochemistry. A fit-for-purpose identity package should combine intact mass with sequence-sensitive or reference-comparison evidence and state the terminal amide.
Analytical and evidence boundary
“GHRP-2 acetate” does not identify acetate stoichiometry or water content. Calculations should specify whether a weighed amount is total material, anhydrous material or peptide equivalent.
WADA status is a sports-governance rule, not a product-quality test. FDA safety statements concern compounded drug products and do not convert a research catalog lot into a medicine.
Editorial rule
State the exact material, form, model or population and endpoint supported by the cited record. Do not convert mechanistic plausibility, an animal result, an official finished-drug label or an analytical test into a claim about an unrelated catalog lot.
Sources & editorial method
This article discusses the source records listed below, with the study models and limitations stated alongside the findings. AI-assisted drafting and image generation were used. The reference list identifies the records behind this article; it is not an independent peer review or verification of a supplied catalog lot.
5 linked records are listed in the references below. Read the editorial and AI-assistance policy.
How to interpret this article
Source-checked on 2026-09-02. Null results, sample size, model/population limits, finished-drug scope, regulatory status and product-evidence boundaries are retained. This is not medical advice, a customer case or validation of a catalog lot.
Research-use boundary: Catalog materials discussed on this website are for laboratory research, development and manufacturing use only, not for human or veterinary use. This content is not medical advice and does not provide administration instructions.
Primary records and authoritative sources
- GHRP-2 and food intake in healthy menSeven-person human crossover physiology study; PMID 15699539.
- Five-day GHRP-2 treatment in healthy menNine-person repeated-response study; PMID 9820615.
- PubChem Pralmorelin recordSequence, stereochemistry, formula and molecular weight; CID 6918245.
- Certain Bulk Drug Substances That May Present Significant Safety RisksU.S. FDA. Current compounding safety-information page.
- WADA 2026 Prohibited ListOfficial list prohibits mechano growth factors.
Continue with structured records
Move from this editorial analysis to the product identity, filtered evidence and controlled terminology behind it.
